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ABSTRACT: Water chlorination can lead to the formation of
disinfection byproducts, including trihalomethanes (THMs).
However, few epidemiologic studies have explored associations
between THM exposure and mortality. This study included 6720
adults aged ≥40 years from the National Health and Nutrition
Examination Survey 1999−2012 who had blood THM concen-
trations quantified. A higher risk of all-cause mortality was found
across increasing quartile concentrations of blood chloroform
(TCM) and total THMs (TTHMs; sum of all four THMs) (both p
for trend = 0.02). Adults in the highest quartile of TCM and
TTHM concentrations had hazard ratios (HRs) of 1.35 (95%
confidence intervals: 1.05−1.74) and 1.37 (1.05−1.79), respec-
tively, for all-cause mortality, compared with adults in the lowest
quartile. When cause-specific mortality was evaluated, a positive relationship was found between blood bromodichloromethane
(BDCM), dibromochloromethane (DBCM), bromoform (TBM), total brominated THMs (Br-THMs; sum of BDCM, DBCM, and
TBM), and TTHM concentrations and risk of cancer death and between blood TCM and TTHMs and risk of other cause
(noncancer/nonheart disease) mortality. Our findings suggest that higher exposure to Br-THMs was associated with increased
cancer mortality risk, whereas TCM was associated with a greater risk of noncancer/nonheart disease mortality.
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1. INTRODUCTION
Water disinfection remains one of the most important global
public health protection strategies and provides safe drinking
water to billions of people by killing disease-causing
pathogens.1 However, when oxidizing agents, including
chemical disinfectants, react with organic and inorganic
materials in raw water, harmful disinfection byproducts
(DBPs) are inadvertently produced.2 Among the more than
600 identified DBPs, trihalomethanes (THMs) are the most
prevalent species in chlorinated water. All four compounds in
the THM group, including chloroform (TCM), bromodi-
chloromethane (BDCM), dibromochloromethane (DBCM),
or bromoform (TBM), have been demonstrated to be
genotoxic and carcinogenic in animal models.3−9 The United
States (U.S.) Environmental Protection Agency (EPA) has
classified BDCM and TBM as probable human carcinogens
and DBCM as a possible human carcinogen10−12 Due to their
high prevalence in drinking water and adverse health effects,
the World Health Organization has assigned guideline values
for TCM (300 μg/L), BDCM (60 μg/L), DBCM (100 μg/L),
and TBM (100 μg/L) in drinking water.13 The U.S. EPA has
regulated total THMs (TTHMs; sum of all four THMs) in
drinking water to 80 μg/L.14 Beyond these limits, the WHO
acknowledges that the ultimate objective is to maintain THM
levels as low as practical in drinking water.13
Epidemiologic studies have revealed associations of THM
exposure with cancer mortality, including bladder, colon, and
rectal cancers.15−17 Blood THMs, which are sensitive to low
levels of exposure, are considered a reliable matrix to measure
steady-state concentrations in human studies.18 Although
blood THMs are eliminated within minutes to hours after
exposure, the high frequency of daily exposure and slow
partitioning out of adipose tissue are believed to produce
steady-state blood concentrations, thus making it a reliable
exposure metric.19 In an early study, Min and colleagues found
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that higher blood concentrations of BDCM, DBCM, TBM,
and total brominated THMs (Br-THMs; sum of BDCM,
DBCM, and TBM) were associated with a higher risk of overall
cancer mortality among 933 U.S. adults aged 40−59 years
from the National Health and Nutrition Examination Survey
(NHANES) 1999−2004.17 Further evidence shows associa-
tions of THM exposure with cardiac and hepatic toxicity,20−22
type 2 diabetes,23,24 as well as adverse reproductive outcomes
(e.g., pregnancy loss),25 suggesting a potential association of
THM exposure with noncancer mortality.26−28 However, no
studies to date have examined associations between THM
exposure with all-cause and other non-cancer-related mortality.
Therefore, we performed the present analysis by including
more recent NHANES data with four additional survey cycles
(1999−2012 vs 1999−2004) and seven times the number of
participants (6720 vs 933) relative to the study conducted by
Min and colleagues, exploring the relationship between blood
THM concentrations and mortality due to all causes, heart
diseases, cancer, and any other causes.
2. METHODS
2.1. Study Participants. NHANES is a nationally
representative program of cross-sectional surveys designed to
evaluate the nutritional and health status of adults and children
in the United States. NHANES combines interviews with
detailed physical examinations and biospecimen collections on
a nationally representative sample of the U.S. civilian
noninstitutionalized population in 2-year increments.29 The
NHANES study protocol was approved by the research ethics
review board of the National Center for Health Statistics, and
all participants signed the informed consent before partic-
ipation. In our current analysis, data were retrieved for
participants who were measured for volatile organic chemicals
(VOCs), including blood THMs, between 1999 and 2012 (n =
14 716).30 We excluded participants who had no linked
mortality data (n = 1890). To avoid major reductions in
population size while at the same time restricting the analysis
to adults at a higher risk of dying,31,32 we also excluded
participants who were less than 40 years of age at time of
recruitment (n = 5420). We further excluded participants who
had missing data on important lifestyle factors such as body
mass index (BMI) (n = 125), alcohol use (n = 558), or
smoking status (n = 3), leaving a final sample size of 6720
participants included in subsequent analyses (Figure 1).
2.2. Exposure Assessment. Whole blood samples were
collected in gray-top glass vacutainers containing potassium
oxalate and sodium fluoride without special instructions (e.g.,
fasting and the sampling time of a given day). To avoid
potential contamination, commercial vacutainers were specially
modified by laboratory staff to remove measurable levels of
most VOCs.33 Because THMs are highly volatile, blood was
drawn by venipuncture and kept at 4 °C during storage and
shipment.34 A detailed description of the laboratory methods
for blood THMs has been reported previously.33 Briefly, blood
TCM, BDCM, DBCM, and TBM concentrations were
measured via solid-phase microextraction gas chromatography
and mass spectrometry,35 which are available in the NHANES
Laboratory data files.30 Blood Br-THMs were calculated by
summing the concentrations of BDCM, DBCM, and TBM;
blood TTHMs were calculated by summing the concentrations
of TCM and Br-THMs.36 Samples with values lower than the
analytical limit of detection (LOD) (range: 0.6−2.1 pg/mL)
were imputed using LOD/√2.37 To maintain the integrity of
laboratory determinations, the NHANES program imple-
mented a comprehensive data quality assurance program,
including measuring the analysis of quality control samples at
the beginning and at the end of each analytical run.33 If the
quality control results for specific analytes were declared “out
of control”, the data for all samples analyzed during that
analytical run were treated as invalid.
2.3. Covariates. Covariates were obtained during inter-
views via questionnaires and included age, sex, race/ethnicity,
family income, educational level, cigarette smoking, alcohol
use, self-reported history of chronic diseases (e.g., diabetes,
Figure 1. Flowchart of cohort population exclusion criteria.
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cancer, chronic obstructive pulmonary disease, hypertension,
and cardiovascular disease), and general health status
(excellent, very good, good, fair, or poor). To capture potential
peak exposure events close to the time of blood sampling,
participants also reported their water-use activities (swimming
pool, hot tub, or steam room) in the past 72 h and time
interval since last shower or bath. Height and weight were
measured during scheduled medical examinations. BMI was
calculated using weight in kilograms divided by height in
meters squared.
2.4. Mortality Ascertainment. Mortality was ascertained
through linkage to the National Death Index from the date of
survey participation through December 31, 2015 (the end of
mortality follow-up data).38 The National Center for Health
Statistics has publicly provided Linked Mortality Files related
to the 1999−2012 NHANES participants with National Death
Index data.38 Our primary outcome was all-cause, total
mortality. Secondary outcomes were defined using underlying
causes of death following the International Classification of
Diseases, 10th Revision (ICD-10) codes for heart diseases
(codes I00−09, I11, I13, I20−51), cancer (codes C00−97),
and any other causes. Person years of follow-up were defined as
the interval from the date of blood sampling to the date of
death or to the end of follow-up (December 31, 2015),
whichever occurred first.
2.5. Statistical Analysis. All analyses incorporated sample
weights, stratification, and clustering of the complex sampling
design of NHANES to ensure nationally representative
estimates.29 Baseline characteristics of living and dead
participants were compared using the t-test for continuous
variables and Chi-square test for categorical groups. Cox
proportional hazard regression models were fit to assess the
hazard ratios (HRs) and 95% confidence intervals (CIs) with
time-to-event as the time variable for the associations between
blood THM concentrations and the risk of all-cause and cause-
specific mortality. Individuals were assigned to quartiles for
TCM, BDCM, Br-THM, and TTHM concentrations. Because
a large proportion of measurements were lower than the LOD
Table 1. Baseline Characteristics of Study Participants in NHANES 1999−2012 [Mean (95% CI) or N (%)]a,b
characteristicc total (n = 6720) censored (n = 5905) event (n = 815) Pd
age (years) 55.1 (54.6, 55.6) 54.1 (53.6, 54.5) 65.2 (63.8, 66.6) <0.001
BMI (kg/m2) 29.0 (28.8, 29.2) 29.0 (28.8, 29.3) 28.7 (28.2, 29.2) 0.20
sex 0.006
male 3378 (49.0) 2903 (48.4) 475 (55.0)
female 3342 (51.0) 3002 (51.6) 340 (45.0)
race/ethnicity 0.03
non-hispanic white 3374 (75.4) 2888 (75.4) 486 (76.3)
non-hispanic black 1375 (9.8) 1205 (9.6) 170 (11.9)
Mexican American 1062 (5.7) 959 (5.7) 103 (5.2)
other 909 (9.1) 853 (9.3) 56 (6.6)
educational level <0.001
less than high school 1919 (17.3) 1581 (15.7) 338 (34.1)
high school 1595 (25.2) 1383 (24.9) 212 (27.6)
college or above 3206 (57.5) 2941 (59.4) 265 (38.3)
family income-to-poverty ratio level <0.001
0−1.0 1031 (8.8) 875 (8.4) 156 (12.9)
1.1−3.0 3048 (36.1) 2590 (34.4) 458 (52.9)
>3.0 2641 (55.1) 2440 (57.2) 201 (34.2)
cigarette smoking <0.001
never 3278 (48.4) 2,960 (49.5) 318 (36.7)
former 2096 (31.2) 1791 (30.9) 305 (34.6)
current 1346 (20.4) 1154 (19.6) 192 (28.7)
alcohol use <0.001
never 2043 (25.2) 1756 (24.5) 287 (32.0)
low to moderate 4038 (63.6) 3594 (64.4) 444 (56.0)
heavy 639 (11.2) 555 (11.1) 84 (12.0)
self-reported chronic diseases <0.001
hypertension 2524 (33.0) 2093 (31.3) 431 (51.4)
diabetes 1052 (11.2) 862 (10.2) 190 (21.7)
cardiovascular diseases 964 (10.8) 689 (8.7) 275 (31.5)
chronic obstructive pulmonary diseases 573 (8.4) 456 (7.8) 117 (14.9)
cancer 644 (8.7) 483 (7.8) 161 (17.5)
self-reported health status <0.001
very good to excellent 2495 (46.7) 2296 (48.7) 199 (26.3)
good 2450 (35.1) 2154 (34.9) 296 (37.3)
poor to fair 1775 (18.2) 1455 (16.4) 320 (37.4)
aAbbreviations: BMI, Body Mass Index; THMs, trihalomethanes; TCM, chloroform; BDCM, bromodichloromethane; DBCM, dibromochloro-
methane; TBM, bromoform; Br-THMs, sum of BDCM, DBCM, and TBM; TTHMs, sum of TCM and Br-THMs. bAll estimates were accounted
for complex survey designs. c6, 489, and 3 participants had missing information on education level, family income-to-poverty ratio, and self-
reported health status, respectively. dP-values were calculated using the Chi-square test for categorical groups and t-test for continuous variables.
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for DBCM (42.4%) and TBM (66.1%), we categorized
individuals into three groups: the low-exposure group with
concentrations <LOD, and the median-, and high-exposure
groups that were equally divided among detectable samples.
Covariates were selected a priori based on prior NHANES
findings,17 which were further added to Cox models if their
inclusion changed the age-adjusted HRs by ≥10%.39 Multi-
variable models were adjusted for age (continuous), sex (male
or female), BMI (<18.5, 18.5−24.9, 25.0−29.9, and ≥30.0 kg/
m2), race/ethnicity (non-Hispanic black, non-Hispanic white,
Mexican American, or other), educational level (lower than
high school, high school, college or above), family income-to-
poverty ratio (0−1.0, 1.1−3.0, or >3.0), cigarette smoking
(never, former, or current), alcohol use (never, low-to-
moderate, or heavy), general health status (very good-to-
excellent, good, or poor-to-fair), and peak exposure events
within 72 h (yes or no). Tests for linear trend were evaluated
by modeling quartiles (or categories) of THM concentrations
as ordinal variables using integer values (i.e., 0−2 or 0−3).
Missing data on family income-to-poverty ratio (n = 489),
education level (n = 6), and self-reported general health status
(n = 3) were replaced by median values.
We explored effect modification by performing analyses
stratified by age at recruitment (<65 vs ≥ 65 years), BMI (<25
vs ≥ 25 kg/m2), sex (male vs female), cigarette smoking status
(never vs ever), alcohol consumption (never vs ever), survey
year (1999−2006 vs 2007−2012), and fasting time (≤10 vs
>10 h). Several sensitivity analyses were also conducted. First,
we ran complete case analyses after excluding participants who
had any missing data to assess the potential bias introduced by
the replacement method by median values. Second, we
excluded participants reporting cardiovascular disease or
cancer at baseline whose mortality risk was less likely to be
influenced by the THMs determined at recruitment. Third, we
excluded participants who died within 1 year after recruitment
as these deaths were not likely influenced by the THMs (or
other factors) after recruitment. Fourth, we additionally
included the timing of examination session (morning,
afternoon, and evening) and the time interval since last
shower or bath as covariates in the Cox models because they
were found to influence blood THM concentrations.40,41 Fifth,
we added age squared term as a covariate in the Cox models to
account for potential nonlinear association between age and
mortality. Finally, as part of a sensitivity analysis, we included
participants who were 20−39 years of age at recruitment to
assess potential population selection bias introduced by our
primary analysis to analyze adults 40 years or older. All data
were analyzed using SAS 9.4 (SAS Institute, Inc., Cary, NC).
3. RESULTS
3.1. Participant Characteristics. We totally included
6720 U.S. adults with a mean age and BMI at recruitment of
55.1 years (95% CI: 54.6−55.6) and 29.0 kg/m2 (95% CI:
28.8−29.2), respectively (Table 1). Compared with partic-
ipants who died during follow-up, adults who remained alive
were more likely to be young females and nonsmokers. They
also had a better educational background, family income-to-
poverty ratio, and general health status, a lower prevalence of
chronic diseases (diabetes, cancer, chronic obstructive
pulmonary disease, hypertension, and cardiovascular disease),
but higher self-reported alcohol consumption.
3.2. Distribution of Blood THM Concentrations. Table
2 shows the distribution of blood THMs, which accounted for
complex survey design by applying survey sample weights. Of
6720 enrolled participants, 6365 (94.7%), 6645 (98.9%), 6550
(97.5%), and 6551 (97.5%) adults had quantified TCM,
BDCM, DBCM, and TBM biomarkers, respectively. The
detection rates of TCM, BDCM, DBCM, and TBM were 91.0,
74.7, 57.6, and 33.9%, respectively. Median blood concen-
trations of TCM, BDCM, DBCM, TBM, Br-THM, and
TTHM were 8.9, 1.4, 0.67, 0.71, 3.3, and 13.9 pg/mL,
respectively.
3.3. Blood THMs and Mortality. During 50 372 person
years of follow-up (median follow-up, 7.1 years; the maximum
follow-up, 16.8 years), 815 deaths occurred, including 207
from cancer, 148 from heart disease, and 460 from other
causes. After adjusting for covariates, we found a positive trend
of higher total all-cause mortality risk across increasing quartile
concentrations of blood TCM and TTHMs (both p for trend
= 0.02). Compared with adults in the lowest quartile,
participants in the highest quartile of TCM and TTHMs had
HRs of 1.35 (95% CI: 1.05−1.74) and 1.37 (1.05−1.79) for
total all-cause mortality, respectively (Table 3). Additionally,
we found a higher risk of all-cause mortality among
participants in the third quartile of BDCM (HR = 1.33; 95%
CI: 1.04−1.71) and those in the highest-exposure categories of
TBM (HR = 1.32; 95% CI: 0.98−1.81) compared with
participants in the lowest-exposure categories, though there
was only weak evidence of dose−response relationship (p for
trend = 0.29 and 0.13, respectively). When cause-specific
mortality was assessed (Table 4), a positive dose−response
relationship was found between blood DBCM and TBM and
cancer mortality risk (HR = 1.65; 1.07−2.55; and HR = 1.91;
1.19−3.08, comparing the highest- vs lowest-exposure
categories) and between blood TCM and TTHMs and risk
of other causes (noncancer/nonheart disease) mortality (HR =
1.61; 1.11−2.33; and HR = 1.55; 1.06−2.27, comparing the
highest- vs lowest-exposure quartiles). Besides, we found a
higher risk of cancer mortality among participants in the third
quartiles of BDCM and TTHMs (HR = 1.84; 1.07−3.17; and
HR = 1.67; 1.02−2.72, respectively) and those in the highest
quartile of Br-THMs (HR = 1.66; 0.94−2.91), compared to
participants in the lowest quartiles. Blood THMs were
unrelated to the risk of mortality due to heart disease.
3.4. Subgroup and Sensitivity Analyses. There was no
evidence of interaction for age, sex, BMI, smoking status,
alcohol use, survey year, and fasting time (Table S1). In
sensitivity analyses, the associations of TCM and TTHMs with
Table 2. Distribution of Blood THM Concentrations in
NHANES Participants 1999−2012a
blood THMs (pg/mL) Nb %>LOD mean (95% CI) median
TCM 6365 91.0 17.3 (15.5, 19.1) 8.9
BDCM 6645 74.7 2.8 (2.5, 3.1) 1.4
DBCM 6550 57.6 1.9 (1.7, 2.1) 0.67
TBM 6551 33.9 2.3 (1.8, 2.9) 0.71
Br-THMs 6366 NA 6.9 (6.2, 7.6) 3.3
TTHMs 6040 NA 23.9 (21.7, 26.1) 13.9
aAbbreviations: LOD, limit of detection; THMs, trihalomethanes;
TCM, chloroform; BDCM, bromodichloromethane; DBCM, dibro-
mochloromethane; TBM, bromoform; Br-THMs, sum of BDCM,
DBCM, and TBM; TTHMs, sum of TCM and Br-THMs; NA, not
applicable. bThe number of samples for THMs is different because
invalid measurements are not reported in the NHANES Laboratory
data files.
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all-cause mortality did not materially change when we excluded
participants who had any missing data or self-reported
prevalent cardiovascular disease or cancer at recruitment,
when we excluded deaths occurring within the first year of
follow-up, and when we additionally included age squared term
or the timing of examination session and the time interval since
last shower or bath as covariates in the Cox models (Table S2).
Our findings were also robust when we further included
participants who were 20−39 years of age at recruitment
(Table S3); these results were consistent with the more
restricted subsample of only adults 40 years and older in our
primary analysis.
4. DISCUSSION
The median blood TCM and BDCM concentrations in our
present study were similar to that of the overall NHANES
population aged >12 years recruited in 2001−2012 (8.88 vs
8.60 and 1.40 vs 1.40 pg/mL, respectively).42 Among 6720
U.S. adults aged 40 years and older at recruitment, we found
that higher blood concentrations of TCM, BDCM, and
TTHMs at enrollment were associated with a greater risk of
all-cause mortality during follow-up. Individuals in the highest-
exposure categories of TCM, TBM, and TTHMs had 35, 32,
and 37% higher risk of all-cause mortality, respectively,
compared with adults in the lowest-exposure categories.
Besides, individuals in the third quartile of BDCM had a
33% higher total all-cause mortality risk than adults in the
lowest quartile. When cause-specific mortality was evaluated,
we found a greater risk of cancer mortality among adults with
higher blood BDCM, DBCM, TBM, Br-THM, and TTHM
concentrations at enrollment, while blood TCM and TTHMs
were associated with a greater risk of noncancer/nonheart
disease mortality.
Accumulating evidence points to an association of THM
exposure with cancer morbidity and mortality in diverse
settings.43−45 In support of our findings, exposure to higher
levels of THMs in drinking water has been associated with a
greater risk of death due to all cancers,15 colon,16 bladder,46,47
Table 3. Hazard Ratios (95% CIs) of All-Cause Mortality According to Blood THM Concentrations (NHANES, 1999−2012)a
HR (95% CI)
THMs (pg/mL) n/person yearsb model 1c model 2d model 3e
TCM
Q1 (≤4.19) 187/11 053 1.00 (reference) 1.00 (reference) 1.00 (reference)
Q2 (4.20−8.90) 194/11 330 1.24(1.01, 1.53) 1.31(1.07, 1.61) 1.31(1.07, 1.61)
Q3 (8.91−18.0) 201/12 040 1.37 (1.11, 1.68) 1.40 (1.14, 1.72) 1.41 (1.14, 1.73)
Q4 (>18.0) 183/12 755 1.33 (1.03, 1.71) 1.34 (1.04, 1.73) 1.35 (1.05, 1.74)
P-trend 0.03 0.02 0.02
BDCM
Q1 (≤ 0.44) 220/12 453 1.00 (reference) 1.00 (reference) 1.00 (reference)
Q2 (0.45−1.49) 201/12 077 1.20 (0.96, 1.51) 1.22 (0.99, 1.52) 1.23 (0.99, 1.52)
Q3 (1.50−3.50) 215/12 793 1.26 (0.99, 1.60) 1.33 (1.03, 1.71) 1.33 (1.04, 1.71)
Q4 (>3.50) 164/12 458 1.02 (0.80, 1.31) 1.08 (0.84, 1.40) 1.08 (0.84, 1.40)
P-trend 0.58 0.29 0.29
DBCM
T1 (≤0.44) 381/21 751 1.00 (reference) 1.00 (reference) 1.00 (reference)
T2 (0.45−1.78) 225/14 039 1.08 (0.89, 1.31) 1.13 (0.92, 1.38) 1.13 (0.92, 1.38)
T3 (>1.78) 198/13 429 1.10 (0.87, 1.41) 1.16 (0.90, 1.49) 1.16 (0.90, 1.49)
P-trend 0.37 0.20 0.20
TBM
T1 (≤1.06) 574/33 065 1.00 (reference) 1.00 (reference) 1.00 (reference)
T2 (1.07−2.12) 107/7 678 0.92 (0.72, 1.18) 0.94 (0.73, 1.22) 0.94 (0.73, 1.22)
T3 (>2.12) 116/8 037 1.24 (0.92, 1.67) 1.33 (0.98, 1.80) 1.32 (0.98, 1.81)
P-trend 0.28 0.14 0.13
Br-THMs
Q1 (≤1.94) 225/11 416 1.00 (reference) 1.00 (reference) 1.00 (reference)
Q2 (1.95−3.48) 190/11 913 1.01 (0.79, 1.29) 1.05 (0.83, 1.33) 1.06 (0.83, 1.34)
Q3 (3.49−7.10) 201/11 997 1.02 (0.79, 1.31) 1.08 (0.83, 1.41) 1.08 (0.83, 1.41)
Q4 (>7.10) 162/12 125 0.97 (0.73 to 1.28) 1.04 (0.78, 1.39) 1.04 (0.78, 1.39)
P-trend 0.85 0.73 0.72
TTHMs
Q1 (≤7.36) 178/10 418 1.00 (reference) 1.00 (reference) 1.00 (reference)
Q2 (7.37−14.14) 205/10 727 1.47 (1.16, 1.87) 1.53 (1.20, 1.94) 1.53 (1.20, 1.94)
Q3 (14.15−26.39) 177/11 322 1.44 (1.11, 1.87) 1.48 (1.12, 1.94) 1.48 (1.13, 1.95)
Q4 (>26.39) 173/12 121 1.29 (0.99, 1.70) 1.36 (1.04, 1.78) 1.37 (1.05, 1.79)
P-trend 0.06 0.03 0.02
aAbbreviations: HR, hazard ratio; 95% CI, 95% confidence interval; THMs, trihalomethanes; TCM, chloroform; BDCM, bromodichloromethane;
DBCM, dibromochloromethane; TBM, bromoform; Br-THMs, sum of BDCM, DBCM, and TBM; TTHMs, sum of TCM and Br-THMs. bThe
number of deaths and person years are absolute, unweighted values. cModel 1 was adjusted for age, sex, cigarette smoking, and self-reported general
health. dModel 2 was additionally adjusted for race/ethnicity, education level, family income-to-poverty ratio level, BMI, and alcohol drinking.
eModel 3 was further adjusted for water-use activity within 72 h.
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and brain cancer.46 Yet, a lack of association between THM
exposure and deaths due to esophageal, rectal, and kidney
cancers was also reported.16,48−50 However, these previous
studies estimated exposure to total THMs from tap water
consumption as a surrogate to assign exposure to individuals,
which could result in exposure misclassification due to the
temporal and spatial variability of monitoring data and within-
and between-individual variability in water usage and
metabolism.41,51 In an earlier NHANES analysis, Min and
colleagues reported a positive association between blood
DBCM, TBM, and Br-THM concentrations and cancer
mortality risk among 933 adults aged 40−59 years,17 which
is in agreement with our updated analysis including a larger
sample size over a longer study follow-up period. Besides, both
studies reported a higher risk of cancer mortality among
participants with moderate levels of blood BDCM concen-
trations, compared to participants in the lowest exposure levels.
In our current analysis, however, we also found that moderate
levels of blood TTHMs were associated with a greater risk of
cancer mortality. Additionally, the hazard ratios of cancer
mortality in relation to blood THM concentrations reported by
Min et al. were slightly higher than our present study. The
discrepancy between studies could be driven by the difference
in population size. One key methodological issue of the
previous NHANES analysis by Min et al. is that only 19 cancer
deaths occurred during the shorter-term follow-up. As a result,
Min and colleagues reported much wider 95% confidence
intervals for the estimated hazard ratios of cancer mortality
related to THMs than that of our present study, indicating
possible insufficient statistical power to generate precise
estimations. In comparison, we analyzed a total of 207 cancer
deaths and our findings were less prone to false positives due
to a larger number of cases.
This study, to our knowledge, is the first to explore the
association between THM exposure and total, all-cause, and
cardiovascular mortality. While some in vivo and in vitro
evidence has supported the cardiac toxicity of THMs,21 we did
not find any convincing associations between blood THMs
Table 4. Hazard Ratios (95% CIs) of Cause-Specific Mortality According to Blood THM Concentrations (NHANES, 1999−
2012)a,b
heart disease cancer other cause
THMs (pg/mL) HR (95% CI) n/person yearsc HR (95% CI) n/person yearsc HR (95% CI) n/person yearsc
TCM
Q1 (≤4.19) 1.00 (reference) 45/11 053 1.00 (reference) 50/11 053 1.00 (reference) 92/11 053
Q2 (4.20−8.90) 1.04 (0.54, 1.99) 32/11 330 1.17 (0.71, 1.92) 44/11 330 1.50 (1.11, 2.04) 118/11 330
Q3 (8.91−18.0) 1.26 (0.72, 2.14) 38/12 040 1.41 (0.92, 2.16) 47/12 040 1.45 (1.07, 1.97) 116/12 040
Q4 (>18.0) 1.00 (0.51, 1.95) 28/12 755 1.15 (0.70, 1.89) 50/12 755 1.61 (1.11, 2.33) 105/12 755
P-trend 0.80 0.43 0.02
BDCM
Q1 (≤ 0.44) 1.00 (reference) 45/12 453 1.00 (reference) 49/12 453 1.00 (reference) 126/12 453
Q2 (0.45−1.49) 1.25 (0.73, 2.14) 41/12 077 1.29 (0.73, 2.26) 50/12 077 1.22 (0.89, 1.67) 110/12 077
Q3 (1.50−3.50) 1.41 (0.86, 2.33) 44/12 793 1.84 (1.07, 3.17) 62/12 793 1.07 (0.74, 1.56) 109/12 793
Q4 (>3.50) 0.55 (0.23, 1.35) 16/12 458 1.43 (0.80, 2.54) 41/12 458 1.11 (0.82, 1.51) 107/12 458
P-trend 0.38 0.09 0.64
DBCM
T1 (≤0.44) 1.00 (reference) 80/21 751 1.00 (reference) 88/21 751 1.00 (reference) 213/21 751
T2 (0.45−1.78) 1.19 (0.74, 1.92) 42/14 039 1.40 (0.90, 2.17) 61/14 039 1.01 (0.78, 1.30) 122/14 039
T3 (>1.78) 0.72 (0.42, 1.23) 25/13 429 1.65 (1.07, 2.55) 56/13 429 1.10 (0.81, 1.49) 117/13 429
P-trend 0.33 0.02 0.58
TBM
T1 (≤1.06) 1.00 (reference) 108/33 065 1.00 (reference) 138/33 065 1.00 (reference) 328/33 065
T2 (1.07−2.12) 0.98 (0.50, 1.90) 16/7678 1.11 (0.71, 1.72) 27/7678 0.85 (0.60, 1.21) 64/7678
T3 (>2.12) 1.29 (0.63, 2.64) 21/8037 1.91 (1.19, 3.08) 37/8037 1.04 (0.71, 1.51) 58/8037
P-trend 0.56 0.01 0.88
Br-THMs
Q1 (≤1.94) 1.00 (reference) 45/11 416 1.00 (reference) 49/11 416 1.0 131/11 416
Q2 (1.95−3.48) 1.14 (0.65, 1.97) 45/11 913 1.55 (0.94, 2.56) 52/11 913 0.85 (0.59, 1.22) 93/11 913
Q3 (3.49−7.10) 1.30 (0.78, 2.16) 38/11 997 1.16 (0.69, 1.98) 50/11 997 0.99 (0.70, 1.38) 113/11 997
Q4 (>7.10) 0.51 (0.24, 1.10) 15/12 125 1.66 (0.94, 2.91) 44/12 125 0.96 (0.68, 1.35) 103/12 125
P-trend 0.16 0.15 0.96
TTHMs
Q1 (≤7.36) 1.00 (reference) 44/10 418 1.00 (reference) 44/10 418 1.00 (reference) 90/10 418
Q2 (7.37−14.14) 0.99 (0.57, 1.72) 32/10 727 1.79 (1.09, 2.93) 51/10 727 1.65 (1.16, 2.35) 122/10 727
Q3 (14.15−26.39) 1.56 (0.97, 2.51) 38/11 322 1.67 (1.02, 2.72) 41/11 322 1.38 (0.93, 2.05) 98/11 322
Q4 (>26.39) 0.88 (0.45, 1.75) 25/12 121 1.41 (0.82, 2.42) 44/12 121 1.55 (1.06, 2.27) 104/12 121
P-trend 0.75 0.27 0.05
aAbbreviations: HR, hazard ratio; 95% CI, 95% confidence interval; THMs, trihalomethanes; TCM, chloroform; BDCM, bromodichloromethane;
DBCM, dibromochloromethane; TBM, bromoform; Br-THMs, sum of BDCM, DBCM, and TBM; TTHMs, sum of TCM and Br-THMs. bModels
were adjusted for age, sex, race/ethnicity, education level, family income-to-poverty ratio level, BMI, alcohol drinking, cigarette smoking, self-
reported general health, and water-use activity within 72 h. cThe number of deaths and person years are absolute, unweighted values.
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exposure and heart disease mortality, which might be due to
the difference in species susceptibility and/or exposure levels
tested in laboratory animals compared with those normally
found in humans.52 Instead, we found a relationship between
elevated blood TCM and TTHM concentrations and a greater
risk of all-cause and cancer mortality risk. Previous
toxicological and epidemiological studies have associated
exposure to THMs with adverse reproductive outcomes,25
neurotoxicity,53 liver injury,34 respiratory impairment,54 and
diabetes.23 These health conditions have been associated with
an increased mortality risk, making potential associations
between THM exposures and total mortality biologically
plausible.
Although the mechanisms underlying the associations
between THM exposure and mortality are not fully under-
stood, many DBPs, including THMs, have been classified as
cytotoxic, mutagenic, or genotoxic based on experimental
animal studies and in vitro assays.54−56 In an observational
study conducted among 50 healthy adults, Kogevinas and
colleagues reported that higher levels of individual Br-THMs in
exhaled breath after swimming were associated with greater
micronuclei counts in peripheral blood lymphocytes and urine
mutagenicity.57 Besides, exposure to THMs was also reported
to be associated with metabolic changes such as protein-free
radical generation, lipid peroxidation, and oxidative stress both
in animals and humans,58−60 which could result in liver
damage, insulin resistance, and diabetes,23,34 eventually leading
to an increased risk of death.
Our study has several limitations. First, we relied on a single
measurement of blood THMs at enrollment to predict death
over the subsequent follow-up period, which may lead to
exposure misclassification. Although a single measurement is
thought to reflect steady-state levels in humans,19 such
misclassification would tend to bias effect estimates toward
the null. Besides, the influence of changes in personal water-use
habits and national reduction in THM levels due to the U.S.
EPA’s preventive policies cannot be fully ruled out.40 As a
result, Ashley and colleagues reported a significant decline in
the levels of TCM in blood and tap water among the U.S.
NHANES population recruited between 2001 and 2012.42 Our
stratified analysis, however, showed no evidence of effect
modification by survey year (1999−2006 vs 2007−2012).
Second, although we have adjusted for an extensive set of
potential confounders such as demographic indicators, self-
reported health conditions, lifestyle factors, and BMI, the
possibility of unmeasured and residual confounding cannot be
fully ruled out.61,62 Third, from 2007 to 2012, NHANES
cause-specific death categories only included heart disease and
cancer. Thus, the leading causes of deaths related to blood
TCM and TTHMs were unclear. Besides, the misclassification
of underlying causes based on the death certificate in the U.S.
cannot be fully ruled out.63 Fourth, causality cannot be
determined because of the observational nature of the study
design. However, we used a nationally representative sample of
U.S. adults with a large sample size and longitudinal study
design and evaluated internal exposure levels (blood
biomarkers of THMs), which greatly improved methodological
issues in previous studies, contributing to higher robustness of
our present findings.
In conclusion, we found positive associations between blood
TCM, BDCM, TBM, and TTHMs and risk of all-cause
mortality; between BDCM, DBCM, TBM, Br-THMs, and
TTHMs and risk of cancer mortality; and between TCM and
TTHMs and risk of noncancer/nonheart disease mortality
among U.S. adults. Although our results should be confirmed
in well-established cohort studies, they provide evidence that
population exposure to THMs may contribute to overall
mortality among U.S. adults.
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